Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?
Authors
Keywords
Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Surgery
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 20, Issue 11, Pages 1867-1873
Publisher
Springer Nature
Online
2016-09-16
DOI
10.1007/s11605-016-3275-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Preoperative Biologic Drugs on Complications and Function After Restorative Proctocolectomy with Primary Ileal Pouch Formation
- (2015) Francesco Selvaggi et al. INFLAMMATORY BOWEL DISEASES
- Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy
- (2014) P. Myrelid et al. BRITISH JOURNAL OF SURGERY
- Initial Surgical Management of Ulcerative Colitis in the Biologic Era
- (2014) Cristina B. Geltzeiler et al. DISEASES OF THE COLON & RECTUM
- Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
- (2014) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of enteral nutritional support on malnourished patients with inflammatory bowel disease by subjective global assessment
- (2014) Pinar Sokulmez et al. Turkish Journal of Gastroenterology
- Anti-TNF alpha in the treatment of ulcerative colitis: A valid approach for organ-sparing or an expensive option to delay surgery?
- (2014) Gianluca Rizzo WORLD JOURNAL OF GASTROENTEROLOGY
- Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients
- (2013) Ali Syed et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Preoperative Smoking Status and Postoperative Complications
- (2013) Marie Grønkjær et al. ANNALS OF SURGERY
- Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis
- (2013) Vincent Billioud et al. Journal of Crohns & Colitis
- Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery
- (2012) Z. Yang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hospitalisations and surgery in Crohn's disease
- (2012) Charles N Bernstein et al. GUT
- The Impact of Obesity on Outcomes Following Major Surgery for Crohnʼs Disease: An American College of Surgeons National Surgical Quality Improvement Program Assessment
- (2011) Marlin W. Causey et al. DISEASES OF THE COLON & RECTUM
- Outcomes of Patients With Crohn's Disease Improved From 1988 to 2008 and Were Associated With Increased Specialist Care
- (2011) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience
- (2011) Gianluca Rizzo et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease
- (2010) Basil S. Nasir et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Impact of the medicare modernization act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis
- (2010) Jalpa A. Doshi et al. ARTHRITIS CARE & RESEARCH
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients
- (2008) Kweku A. Appau et al. JOURNAL OF GASTROINTESTINAL SURGERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started